BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18594780)

  • 1. Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia.
    Huang KP; Chase AJ; Cross NCP; Reiter A; Li TY; Wang TF; Chu SC; Lu XY; Li CC; Kao RH
    Int J Hematol; 2008 Sep; 88(2):197-201. PubMed ID: 18594780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene.
    Bousquet M; Quelen C; De Mas V; Duchayne E; Roquefeuil B; Delsol G; Laurent G; Dastugue N; Brousset P
    Oncogene; 2005 Nov; 24(48):7248-52. PubMed ID: 16091753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.
    Reiter A; Walz C; Watmore A; Schoch C; Blau I; Schlegelberger B; Berger U; Telford N; Aruliah S; Yin JA; Vanstraelen D; Barker HF; Taylor PC; O'Driscoll A; Benedetti F; Rudolph C; Kolb HJ; Hochhaus A; Hehlmann R; Chase A; Cross NC
    Cancer Res; 2005 Apr; 65(7):2662-7. PubMed ID: 15805263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A t(8;9)(p22;p24)/PCM1-JAK2 translocation in a patient with myeloproliferative neoplasm and myeloid sarcoma: first report in Korea.
    Song I; Lee DH; Lee JH; Jang S; Huh JR; Seo EJ
    Ann Lab Med; 2016 Jan; 36(1):79-81. PubMed ID: 26522767
    [No Abstract]   [Full Text] [Related]  

  • 5. A myeloproliferative neoplasm with translocation t(8;9)(p22;p24) involving JAK2 gene.
    Saba N; Safah H
    Blood; 2013 Aug; 122(6):861. PubMed ID: 24079014
    [No Abstract]   [Full Text] [Related]  

  • 6. A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia.
    Cirmena G; Aliano S; Fugazza G; Bruzzone R; Garuti A; Bocciardi R; Bacigalupo A; Ravazzolo R; Ballestrero A; Sessarego M
    Cancer Genet Cytogenet; 2008 Jun; 183(2):105-8. PubMed ID: 18503828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology of the bone marrow and spleen in a case of myelodysplastic/myeloproliferative neoplasm associated with t(8;9)(p22;p24) involving PCM1 and JAK2 genes.
    Dargent JL; Mathieux V; Vidrequin S; Deghorain X; Vannuffel P; Rack K
    Eur J Haematol; 2011 Jan; 86(1):87-90. PubMed ID: 21070368
    [No Abstract]   [Full Text] [Related]  

  • 8. PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation.
    Murati A; Gelsi-Boyer V; Adélaïde J; Perot C; Talmant P; Giraudier S; Lodé L; Letessier A; Delaval B; Brunel V; Imbert M; Garand R; Xerri L; Birnbaum D; Mozziconacci MJ; Chaffanet M
    Leukemia; 2005 Sep; 19(9):1692-6. PubMed ID: 16034466
    [No Abstract]   [Full Text] [Related]  

  • 9. Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study.
    Tang G; Sydney Sir Philip JK; Weinberg O; Tam W; Sadigh S; Lake JI; Margolskee EM; Rogers HJ; Miranda RN; Bueso-Ramos C C; Hsi ED; Orazi A; Hasserjian RP; Arber DA; Bagg A; Wang SA
    Mod Pathol; 2019 Apr; 32(4):490-498. PubMed ID: 30401948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunophenotypic features of acute myeloid leukemia with AML-1/ETO fusion gene].
    Zhang JJ; DU X; Huang ZX; Su JH; Zhou MH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):378-81. PubMed ID: 17493351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
    Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
    Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ruxolitinib inhibits transforming JAK2 fusion proteins in vitro and induces complete cytogenetic remission in t(8;9)(p22;p24)/PCM1-JAK2-positive chronic eosinophilic leukemia.
    Lierman E; Selleslag D; Smits S; Billiet J; Vandenberghe P
    Blood; 2012 Aug; 120(7):1529-31. PubMed ID: 22899477
    [No Abstract]   [Full Text] [Related]  

  • 13. CD7+ near-tetraploid acute myeloblastic leukemia M2 with double t(8;21)(q22;q22) translocations and Aml1/ETO rearrangements detected by fluorescence in situ hybridization analysis.
    Yamamoto K; Nagata K; Kida A; Tsurukubo Y; Hamaguchi H
    Int J Hematol; 2001 Oct; 74(3):316-21. PubMed ID: 11721969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric acute myeloid leukemia with t(7;21)(p22;q22).
    Paulraj P; Diamond S; Razzaqi F; Ozeran JD; Longhurst M; Andersen EF; Toydemir RM; Hong B
    Genes Chromosomes Cancer; 2019 Aug; 58(8):551-557. PubMed ID: 30706625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates.
    Patnaik MM; Knudson RA; Gangat N; Hanson CA; Pardanani A; Tefferi A; Ketterling RP
    Eur J Haematol; 2010 Jun; 84(6):518-24. PubMed ID: 20331734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2).
    Medeiros BC; Kohrt HE; Arber DA; Bangs CD; Cherry AM; Majeti R; Kogel KE; Azar CA; Patel S; Alizadeh AA
    Leuk Res; 2010 May; 34(5):594-7. PubMed ID: 19781775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myelogenous leukemia with t(8;21)--identification of a specific immunophenotype.
    Khoury H; Dalal BI; Nevill TJ; Horsman DE; Barnett MJ; Shepherd JD; Toze CL; Conneally EA; Sutherland HJ; Hogge DE; Nantel SH
    Leuk Lymphoma; 2003 Oct; 44(10):1713-8. PubMed ID: 14692523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three way translocation in a new variant of t(8;21) acute myeloid leukemia involving Xp22.
    Vundinti BR; Kerketta L; Madkaikar M; Jijina F; Ghosh K
    Indian J Cancer; 2008; 45(1):30-2. PubMed ID: 18453738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK the trigger.
    Mahon FX
    Oncogene; 2005 Nov; 24(48):7125-6. PubMed ID: 16007127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated genomic analysis using chromosomal microarray, fluorescence in situ hybridization and mate pair analyses: Characterization of a cryptic t(9;22)(p24.1;q11.2)/BCR-JAK2 in myeloid/lymphoid neoplasm with eosinophilia.
    Snider JS; Znoyko I; Lindsey KG; Morse J; Baughn LB; Hoppman NL; Pitel BA; Pearce KE; Schandl CA; Wolff DJ
    Cancer Genet; 2020 Aug; 246-247():44-47. PubMed ID: 32827877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.